Discover 1,609 paid clinical trials in Raleigh, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,609
Active & Responsive
Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)
for
Muscular Dystrophy, Facioscapulohumeral
Location: Durham NC, Rochester NY, Kansas City KS
Sponsor: University of Kansas Medical Center
Sex: All
Age: 5 - 17
Code: NCT06847282
Recruiting
Active & Responsive
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Location: Durham NC, Chapel Hill NC, Greensboro NC,
Sponsor: Duke University
Sex: All
Age: 21+
Code: NCT01915511
Recruiting
Active & Responsive
Pediatric Post-Approval Registry
for
Obstructive Sleep Apnea
Location: Durham NC, Norfolk VA, Sewickley PA, Philadelphia PA,
Sponsor: Inspire Medical Systems, Inc.
Sex: All
Age: 18 - 21
Code: NCT04457154
Recruiting
Active & Responsive
A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle
for
Chondral Defect, Articular Cartilage Defect
Location: Durham NC, Charlottesville VA, Washington D.C. DC,
Sponsor: Vericel Corporation
Sex: All
Age: 17 - 65
Code: NCT06915233
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
for
Parkinson Disease
Location: Durham NC, Asheville NC, Augusta GA, Lexington KY,
Sponsor: Appello Pharmaceuticals, Inc.
Sex: All
Age: 30 - 70+
Code: NCT07432958
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
for
Ductal Carcinoma in Situ
Location: Durham NC, Winston-Salem NC, Richmond VA, Atlanta GA,
Sponsor: QuantumLeap Healthcare Collaborative
Sex: Female
Age: 18+
Code: NCT06075953
Phase2, Recruiting
Active & ResponsiveNew
Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib